ERBB2 and malignant colon neoplasm: In addition, recent clinical investigations (Berney et al, 1998; Allgayer et al, 2000) demonstrated an association between ERBB2 overexpression and tumour-associated proteolysis in gastric and colon cancer, suggesting a direct role for ERBB2 in invasion and metastasis through upregulation of proteolytic enzymes.